148 related articles for article (PubMed ID: 3500509)
1. Comparative biochemical pharmacology of the oxicams.
Fenner H
Scand J Rheumatol Suppl; 1987; 65():97-101. PubMed ID: 3500509
[TBL] [Abstract][Full Text] [Related]
2. Comparative biochemical pharmacology of the oxicams.
Fenner H
Eur J Rheumatol Inflamm; 1987; 9(2):3-7. PubMed ID: 3447908
[TBL] [Abstract][Full Text] [Related]
3. Effects of tenoxicam on superoxide anion formation, beta-glucuronidase release and fMLP binding in human neutrophils: comparison with other NSAIDs.
Colli S; Colombo S; Tremoli E; Stragliotto E; Nicosia S
Pharmacol Res; 1991 May; 23(4):367-79. PubMed ID: 1652137
[TBL] [Abstract][Full Text] [Related]
4. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Gonzalez JP; Todd PA
Drugs; 1987 Sep; 34(3):289-310. PubMed ID: 3315620
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT; Brunetto AV; Mattila MJ
Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
[TBL] [Abstract][Full Text] [Related]
6. Overview on the pharmacokinetics of tenoxicam.
Guentert TW; Heintz RC; Joly R
Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
[TBL] [Abstract][Full Text] [Related]
7. Tenoxicam used as a parenteral formulation for acute pain in rheumatic conditions.
Jeunet F; Enz W; Guentert T
Scand J Rheumatol Suppl; 1989; 80():59-61. PubMed ID: 2595344
[TBL] [Abstract][Full Text] [Related]
8. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.
Todd PA; Clissold SP
Drugs; 1991 Apr; 41(4):625-46. PubMed ID: 1711963
[TBL] [Abstract][Full Text] [Related]
9. [Clinical pharmacology of non-steroidal anti-inflammatory drugs. A new benzothiazine derivative: cinnoxicam].
Bertè F; Richelmi P
Minerva Med; 1988 Sep; 79(9):811-30. PubMed ID: 3050617
[No Abstract] [Full Text] [Related]
10. [Tenoxicam].
Friis J
Ugeskr Laeger; 1988 Oct; 150(42):2542. PubMed ID: 3264638
[No Abstract] [Full Text] [Related]
11. [Cytogenetic studies of human lymphocytes under the influence of oxicams].
Kullich W; Hermann J; Klein G
Z Rheumatol; 1990; 49(2):77-81. PubMed ID: 2349840
[TBL] [Abstract][Full Text] [Related]
12. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
Benveniste C; Striberni R; Dayer P
Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
[TBL] [Abstract][Full Text] [Related]
13. Single and multiple dose pharmacokinetics of tenoxicam in the elderly.
Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E
Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs).
Schmitt M; Guentert TW
Scand J Rheumatol Suppl; 1989; 80():86-9. PubMed ID: 2688082
[TBL] [Abstract][Full Text] [Related]
15. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
Fiszman P; Perpétuo JB; Sidi A
Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of tenoxicam at different dosage regimes.
Scaglione F; Demartini G; Dugnani S; Fraschini F; Triscari FA
Farmaco; 1993 Sep; 48(9):1321-5. PubMed ID: 8259988
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics].
Putilina MV; Teplova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290
[TBL] [Abstract][Full Text] [Related]
18. Oral tenoxicam for peripheral orthopaedic surgery: a pharmacokinetic study.
Blake DW; Bjorksten AR; Libreri FC
Anaesth Intensive Care; 1997 Apr; 25(2):142-6. PubMed ID: 9127656
[TBL] [Abstract][Full Text] [Related]
19. Tenoxicam compared with diclofenac in patients with ankylosing spondylitis.
Schwarzer AC; Cohen M; Arnold MH; Kelly D; McNaught P; Brooks PM
Curr Med Res Opin; 1990; 11(10):648-53. PubMed ID: 2178870
[TBL] [Abstract][Full Text] [Related]
20. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.
Balfour JA; Fitton A; Barradell LB
Drugs; 1996 Apr; 51(4):639-57. PubMed ID: 8706598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
